BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24853824)

  • 1. Longitudinal change in working memory as a function of APOE genotype in midlife and old age.
    Greenwood PM; Espeseth T; Lin MK; Reinvang I; Parasuraman R
    Scand J Psychol; 2014 Jun; 55(3):268-77. PubMed ID: 24853824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
    Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
    Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE moderates compensatory recruitment of neuronal resources during working memory processing in healthy older adults.
    Scheller E; Peter J; Schumacher LV; Lahr J; Mader I; Kaller CP; Klöppel S
    Neurobiol Aging; 2017 Aug; 56():127-137. PubMed ID: 28528773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife.
    Zokaei N; Giehl K; Sillence A; Neville MJ; Karpe F; Nobre AC; Husain M
    Cortex; 2017 Mar; 88():98-105. PubMed ID: 28086184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
    Caselli RJ; Dueck AC; Osborne D; Sabbagh MN; Connor DJ; Ahern GL; Baxter LC; Rapcsak SZ; Shi J; Woodruff BK; Locke DE; Snyder CH; Alexander GE; Rademakers R; Reiman EM
    N Engl J Med; 2009 Jul; 361(3):255-63. PubMed ID: 19605830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the APOE genotype on brain function across the lifespan.
    Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
    Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
    Caselli RJ; Dueck AC; Locke DE; Sabbagh MN; Ahern GL; Rapcsak SZ; Baxter LC; Yaari R; Woodruff BK; Hoffman-Snyder C; Rademakers R; Findley S; Reiman EM
    Neurology; 2011 Mar; 76(12):1078-84. PubMed ID: 21325652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
    Shen S; Zhou W; Chen X; Zhang J;
    Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
    Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
    JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
    Mormino EC; Betensky RA; Hedden T; Schultz AP; Ward A; Huijbers W; Rentz DM; Johnson KA; Sperling RA; ; ;
    Neurology; 2014 May; 82(20):1760-7. PubMed ID: 24748674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Daily Physical Activity by Alzheimer's Risk Markers Among Older Adults.
    Marino FR; Deal JA; Dougherty RJ; Bilgel M; Tian Q; An Y; Simonsick EM; Resnick SM; Ferrucci L; Spira AP; Wanigatunga AA; Schrack JA
    J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38742659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E ε4 allele impairs cortical activity in healthy aging and Alzheimer's disease.
    Pedroso RV; Fraga FJ; Nascimento CMC; Pott-Junior H; Cominetti MR
    Behav Brain Res; 2022 Feb; 420():113700. PubMed ID: 34871705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
    Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
    Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Worry Level on Recall Memory for Odors in ApoE-ε4 Carriers and Non-Carriers.
    Bower ES; Szajer J; Murphy C
    J Int Neuropsychol Soc; 2019 May; 25(5):546-556. PubMed ID: 30987686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.